Orchid Chemicals and Pharmaceuticals Ltd

Trending Articles

  1. Johnson & Johnson completes V-Wave acquisition to support patients with heart failure The strategic acquisition will bolster the pharma giant's MedTech offerings for patients with cardiovascular disease
  2. Aveva World 2024 highlights increasing efficiency with Shiftconnector and AI Live demo to showcase real-time data and AI-powered troubleshooting
  3. Rousselot Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
  4. Merck's MilliporeSigma cuts the ribbon on €290m US biosafety and analytical facility The site will host biosafety testing, analytical development and cell banking manufacturing services
  5. Hubble Therapeutics selects Andelyn Biosciences to manufacture its AAVs The CDMO will be responsible for the manufacture of adeno-associated viruses in order to treat leber congenital amaurosis 16

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Finance

Hospira completes purchase of Orchid\'s API manufacturing and R&D facility

US$218m acquisition paves way for future development
Pharmaceutical

Indian manufacturers set to cash in on US generics market

Indian pharma companies are well positioned to generate strong revenues from the US generics market
Pharmaceutical

New anti-infectives company formed

Allecra Therapeutics to develop novel antibiotics to combat multi drug-resistant bacterial infections
You need to be a subscriber to read this article.
Click here to find out more.
Finance

Mega deals and job cuts

Mergers and acquisitions, job cuts as companies streamlined their operations and cut costs, and investments in new plants were the main features of the pharmaceutical industry in 2012
Ingredients

Hospira to buy API manufacturing and r&d facilities in India

Purchase from Orchid will support continuity of antibiotic API supply
Finance

Hospira completes acquisition of Orchid's generic injectables business

Gains new manufacturing capabilities and expands global reach
Subscribe now